Core Viewpoint - Analysts expect The Beauty Health Company (SKIN) to report a quarterly loss of -$0.07 per share, reflecting a year-over-year increase of 12.5%, with revenues projected at $78.17 million, down 6.4% from the previous year [1] Financial Projections - The consensus EPS estimate for the upcoming quarter has remained unchanged over the past 30 days, indicating a reassessment of initial projections by covering analysts [1] - Analysts predict 'Delivery Systems Net Sales' to be $20.85 million, representing a year-over-year decline of 22.2% [4] - The average estimate for 'Consumables Net Sales' is $57.34 million, indicating a slight year-over-year increase of 1.1% [4] - 'Geographic Revenue- Americas' is expected to reach $53.65 million, reflecting a decrease of 6% from the year-ago quarter [4] - 'Geographic Revenue- EMEA' is projected at $17.20 million, while 'Geographic Revenue- Asia Pacific (APAC)' is expected to be $7.49 million, showing a year-over-year decline of 18.6% [5] Market Performance - Shares of Beauty Health have decreased by 10.9% over the past month, contrasting with a 2.7% decline in the Zacks S&P 500 composite [5] - The company holds a Zacks Rank 4 (Sell), suggesting it is expected to underperform the overall market in the near future [5]

Integer Holdings Corporation (ITGR) Fourth Quarter 2025 Earnings Conference Call February 19, 2026 Presenters and Agenda Today's agenda: Kristen Stewart, CFA Director, Investor Relations CONFIDENTIAL | February 19, 2026 | 2 ITGR: 4Q25 Earnings Conference Call Payman Khales President, Chief Executive Officer Diron Smith Executive Vice President, Chief Financial Officer • Opening Remarks • Strategy Update • Financial Results • Financial Outlook • Wrap-up • Q&A Presentation of Financial Information & Forward-L ...

Core Insights - The Beauty Health Company (SKIN) reported a revenue of $78.2 million for the quarter ended June 2025, reflecting a year-over-year decline of 13.7% [1] - The earnings per share (EPS) was $0.03, a significant improvement from -$0.10 in the same quarter last year, indicating a positive shift in profitability [1] - The reported revenue exceeded the Zacks Consensus Estimate of $74.55 million by 4.89%, while the EPS surpassed the consensus estimate of -$0.06 by 150% [1] Revenue Breakdown - Geographic Revenue in the Americas was $52 million, slightly above the average estimate of $51.35 million, but down 9.9% year-over-year [4] - EMEA revenue reached $18.4 million, exceeding the estimated $16.23 million, but still down 4.2% compared to the previous year [4] - Asia Pacific revenue was reported at $7.7 million, significantly higher than the estimated $5.63 million, but this represented a substantial decline of 43.4% year-over-year [4] Sales Performance - Delivery Systems Net Sales amounted to $22.4 million, surpassing the average estimate of $19.43 million, but down 36.4% from the year-ago quarter [4] - Consumables Net Sales were reported at $55.8 million, slightly above the average estimate of $55.34 million, with a modest year-over-year increase of 0.7% [4] Stock Performance - Over the past month, shares of Beauty Health have declined by 23.9%, contrasting with the Zacks S&P 500 composite's increase of 1.2% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]

Core Insights - The Beauty Health Company (SKIN) reported a revenue of $69.6 million for the quarter ended March 2025, reflecting a year-over-year decline of 14.5% [1] - The earnings per share (EPS) was -$0.08, an improvement from -$0.10 in the same quarter last year, with a positive surprise of 38.46% compared to the consensus estimate of -$0.13 [1] - The reported revenue exceeded the Zacks Consensus Estimate of $63.12 million by 10.26% [1] Financial Performance Metrics - Total delivery systems sold reached 862, surpassing the average estimate of 573 based on two analysts [4] - The active install base was reported at 35,014, slightly below the average estimate of 35,090 [4] - Geographic revenue breakdown showed: - Americas: $46.30 million, exceeding the estimate of $43.49 million, but down 8% year-over-year [4] - EMEA: $15 million, above the estimate of $13.60 million, with a year-over-year decline of 21.5% [4] - Asia Pacific: $8.30 million, surpassing the estimate of $6.98 million, down 30.8% year-over-year [4] - Delivery Systems Net Sales were $20.20 million, exceeding the estimate of $14.30 million, but down 43.6% year-over-year [4] - Consumables Net Sales reached $49.40 million, slightly above the estimate of $48.24 million, reflecting an increase of 8.3% year-over-year [4] Stock Performance - Shares of Beauty Health have increased by 31.5% over the past month, outperforming the Zacks S&P 500 composite, which rose by 11.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]